Cairo – Mubasher: The board of directors of Kahira Pharmaceuticals approved the appointment of Adel Taha Abdel Wahab as the company’s Chairman.
The company also named Yasser Ahmed Farghaly as the Managing Director, according to a bourse disclosure on Sunday.
During the first nine months of fiscal year (FY) 2020/2021, Kahira Pharmaceuticals achieved net profits of EGP 102.9 million, up from EGP 92.23 million in the prior-year period.
